Moderate EvidencePromising research with growing clinical support from multiple studies
Holistic Treatment for High Cholesterol
High cholesterol—more precisely, dyslipidemia—refers to unfavorable levels of LDL (“bad”) cholesterol, HDL (“good”) cholesterol, and triglycerides that increase the risk of atherosclerotic cardiovascular disease (ASCVD), including heart attack and stroke. A holistic view looks at both risk reduction from proven biomedical therapies and the broader lifestyle, dietary, and mind–body factors emphasized in Eastern traditions. Comparing these perspectives helps people understand what reliably lowers events, what may support lipid balance, and how to coordinate care safely.
From a Western standpoint, LDL is a primary driver of plaque formation in arteries. Standard care assesses a fasting or nonfasting lipid panel, screens for secondary causes (thyroid, kidney, liver, medications), and uses global risk calculators to estimate 10-year ASCVD risk. Evidence is strongest for statins, which lower LDL and reduce heart attacks, strokes, and cardiovascular mortality across many populations. For those who need more LDL lowering or cannot take statins, ezetimibe and PCSK9 inhibitors further reduce LDL; clinical trials show additional event reduction when these are added to statins in higher-risk groups. Lifestyle measures—nutrient-dense dietary patterns (e.g., Mediterranean-style), weight management, regular physical activity, and avoidance of tobacco—support lipid improvements and overall risk reduction. Western medicine is clear on expected outcomes: the greater and more sustained the LDL reduction, the larger the reduction in cardiovascular events. Limitations include statin-associated muscle symptoms in a minority of people, small risks like new-onset diabetes in predisposed individuals, and access/cost issues for newer agents.
Eastern systems conceptualize dyslipidemia through functional patterns rather than isolated numbers. In Traditional Chinese Medicine (TCM), high lipids are often framed as “phlegm-dampness,” stagnation of Liver Qi, and “blood stasis.” Treatment aims to
cardiovascular
Updated March 17, 2026